Cue Biopharma CUE
NASDAQ CUE
$18.66 -0.23 (-1.22%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cue Biopharma (CUE) Gains from Sales and Divestitures (2019 - 2025)

Updated

Cue Biopharma's Gains from Sales and Divestitures came in at $20,000 for Q4 2025, compared with -$4,000 a year earlier.

Analysis

Cue Biopharma (CUE) Gains from Sales and Divestitures (2019 - 2025) Analysis & Trends

For FY2025, Cue Biopharma's Gains from Sales and Divestitures was -$31,000.

  • Going back by year, Gains from Sales and Divestitures was $93,000 in FY2024, -$157,000 in FY2023, -$4,000 in FY2022 and $21,550 in FY2021.
  • The Q4 2025 figure represents the highest quarterly Gains from Sales and Divestitures since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Cue Biopharma 117.65 Mn 26.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 20,000.00
Sep 30, 2025 -51,000.00
Dec 31, 2024 -4,000.00
Sep 30, 2024 98,000.00
Jun 30, 2024 -1,000.00
Dec 31, 2023 -159,000.00
Mar 31, 2023 2,000.00
Jun 30, 2022 -4,000.00
Dec 31, 2021 550.00
Sep 30, 2021 2,000.00
Dec 31, 2019 -274.00
API Access

Cue Biopharma Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=CUE&period=max&api_key=YOUR_API_KEY